Related Experiment Video
Updated: May 22, 2025

03:53
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
1.0K
MEFV gene variations in COVID-19 pneumonia patients (Pilot study)
Noha A Radwan1, Heba El Gohary1, Dalia Hamed1
1Departement of Clinical and Chemical Pathology, Kasr Alainy Medical School, Cairo University, Egypt.
Journal, Genetic Engineering & Biotechnology
|March 12, 2025
Summary
Variants in the MEFV gene were found in 26% of COVID-19 patients. These MEFV gene variants were associated with moderate COVID-19 pneumonia, suggesting a role in disease severity.
Area of Science:
- Genetics
- Infectious Diseases
- Molecular Biology
Background:
- Coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2 has significantly impacted daily life.
- Familial Mediterranean Fever (FMF) patients exhibit symptoms and laboratory findings similar to COVID-19 patients.
- Investigating genetic factors in COVID-19 severity is crucial.
Purpose of the Study:
- To evaluate the presence of variants in exon 10 of the MEFV gene.
- To determine the relationship between MEFV gene variants and the severity of COVID-19 pneumonia.
Main Methods:
- Thirty-nine COVID-19 patients were categorized into moderate and severe groups.
- Sanger sequencing was performed on exon 10 of the MEFV gene in all subjects.
Main Results:
- MEFV gene variants were identified in 10 out of 39 patients (26%).
- The most common variants included silent p.(P706=) (12.9%), missense p.(A744S) (7.7%), and p.(V726A) (5.1%).
- Notably, 90% of patients with MEFV variants presented with moderate symptoms and did not progress to severe COVID-19 pneumonia.
Conclusions:
- The presence of MEFV gene variants, regardless of their classification (benign or uncertain significance), may influence the severity of COVID-19.
- Further research is warranted to elucidate the protective mechanisms conferred by these variants.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
13.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
13.8K
Viral Mutations
32.1K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.1K
Master Transcription Regulators
6.8K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.8K
Leaky Scanning
5.0K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.0K

